Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (8655)

Company Market Cap Price
LGCL Lucas GC Limited Ordinary Shares
SaaS - Enterprise Software for cloud-based business applications.
$6.32M
$3.19
+16.42%
FLYE Fly-E Group, Inc. Common Stock
Develops Fly-E-Bike app as a software platform; aligns with vertical SaaS software concepts.
$6.27M
$0.50
-1.49%
EVAX Evaxion Biotech A/S
Provides an AI/ML platform (AI-Immunology) with EvaxMHC and EDEN for vaccine target prediction and vaccine design.
$6.24M
$5.70
-0.87%
KAVL Kaival Brands Innovations Group, Inc.
GoFire intellectual property and its monetization/royalties constitute an Intellectual Property Licensing business line.
$6.22M
$0.52
-9.60%
JCSE JE Cleantech Holdings Limited
Company designs, manufactures, and sells precision cleaning systems used in semiconductor and HDD manufacturing, i.e., semiconductor equipment.
$6.21M
N/A
MODV ModivCare Inc.
MODV’s technology platform is a vertical SaaS solution for healthcare operations across its segments.
$6.19M
$0.43
IPDN Professional Diversity Network, Inc.
RemoteMore and IPDN Recruits are cloud-based vertical software platforms (SaaS) for recruitment and remote hiring.
$6.19M
$3.02
-5.92%
VISL Vislink Technologies, Inc.
Vislink develops and sells wireless camera systems (e.g., HCAM) and imaging products for live video capture.
$6.14M
$2.53
KITT Nauticus Robotics, Inc.
ToolKITT is an AI-driven platform; aligns with AI/ML Platforms in software for autonomous systems.
$6.13M
$1.49
-9.70%
SPTY Specificity, Inc.
Core product is a programmatic advertising platform enabling AI-driven, bot-free ad buying across multiple channels.
$6.12M
$0.45
CENN Cenntro Electric Group Limited
Operates cloud-based platforms for vehicle management and control, indicating cloud infrastructure/software usage.
$6.11M
$0.20
-5.00%
TRSO Transuite.Org Inc.
Company sells an AI social agent platform and AWaaS service enabling enterprise AI workloads.
$6.10M
$0.25
PRKR ParkerVision, Inc.
ParkerVision's core business is licensing and monetizing its RF patent portfolio, i.e., intellectual property licensing.
$6.04M
$0.25
YOUL Youlife Group Inc. American Depositary Shares
YOUL provides a vertically-focused SaaS platform for vocational education, HR, and employee management (education-focused software).
$6.02M
$1.88
-2.08%
CYCN Cyclerion Therapeutics, Inc.
The company monetizes its intellectual property through licensing deals and milestone-based payments.
$5.97M
$1.82
-2.41%
WNLV Winvest Group Ltd.
Launchrr is a proprietary SaaS platform focused on content distribution automation and delivery metrics (vertical software).
$5.87M
$0.05
BMTM Bright Mountain Media, Inc.
Core programmatic advertising platform enabling automated ad buying and optimization across display, video, audio, CTV and in-app formats.
$5.84M
$0.04
BNGO Bionano Genomics, Inc.
VIA is a software platform for analyzing OGM data, aligning with AI/ML Platforms.
$5.79M
$1.71
-5.00%
VYNE VYNE Therapeutics Inc.
Company has an exclusive worldwide license for a BET inhibitor library, constituting Intellectual Property Licensing.
$5.77M
$0.34
-4.05%
XTLB XTL Biopharmaceuticals Ltd.
Business model includes licensing of intellectual property (hCDR1) via collaborations (e.g., with Yeda).
$5.72M
$1.06
-0.93%
ONFO Onfolio Holdings, Inc.
Precision Metrics Custom Dashboards indicate BI/Analytics software/services.
$5.69M
$1.09
HSCS HeartSciences Inc.
MyoVista Insights Cloud Platform and AI algorithms constitute an AI/ML platform for ECG analytics.
$5.67M
$2.93
-3.93%
MAXN Maxeon Solar Technologies, Ltd.
The content highlights monetization of an extensive IP portfolio and licensing arrangements.
$5.51M
$3.58
-1.10%
BUDZ WEED, Inc.
Potential licensing of proprietary cannabis/genomics IP and related technologies.
$5.44M
$0.04
APCX AppTech Payments Corp.
FinZeo is a cloud-based SaaS platform specialized for fintech, i.e., SaaS - Vertical Software.
$5.42M
$0.16
MKDW MKDWELL Tech Inc.
Direct Vehicle Telematics Hardware: MKDWELL is described as a vehicle electronics hardware company, including telematics devices used in fleet/vehicle applications.
$5.38M
$0.21
+5.19%
NAKA Kindly MD, Inc.
Edm-based enterprise software platform underpinning healthcare data management and care optimization.
$5.35M
$0.89
-4.49%
ZDPY Zoned Properties, Inc.
The PropTech platform uses AI-powered tools for lead generation and deal flow optimization, aligning with AI/ML Platforms.
$5.32M
$0.44
CAPS Capstone Holding Corp.
Capstone's website-centric dealer purchasing model constitutes an online e-commerce platform for building materials.
$5.29M
$1.01
-0.49%
LUCY Innovative Eyewear, Inc.
Core product is eyewear with built-in audio functionality (headphones) integrated into smart glasses.
$5.29M
$1.72
-0.87%
RIME Algorhythm Holdings, Inc.
Algorhythm's SemiCab is an AI-enabled software platform for logistics optimization, i.e., AI/ML Platforms.
$5.26M
$2.10
-0.71%
WCT Wellchange Holdings Company Limited
MR. CLOUD is a SaaS enterprise software platform, aligning with Enterprise Software (SaaS).
$5.19M
$0.25
-2.95%
← Previous
1 ... 80 81 82 83 84 ... 87
Next →
Showing page 82 of 87 (8655 total stocks)

Loading company comparison...

Loading research report...

EVAX Evaxion Biotech A/S

Evaxion Secures $7.2 Million in Financing, Extending Cash Runway to 2027

Oct 30, 2025
EVAX Evaxion Biotech A/S

Evaxion Names Dr Helen Tayton‑Martin as New CEO

Oct 27, 2025
PRKR ParkerVision, Inc.

Court of Appeals Grants ParkerVision Expedited Appeal in Qualcomm Patent Case

Oct 23, 2025
SPTY Specificity, Inc.

Specificity Names Robert Fedder as New Chief Executive Officer

Oct 20, 2025
EVAX Evaxion Biotech A/S

Evaxion Reports 75% Objective Response Rate in Phase 2 Trial of AI‑Designed Cancer Vaccine EVX‑01

Oct 17, 2025
EVAX Evaxion Biotech A/S

Evaxion to Present New EVX-01 Biomarker Data at SITC 2025 Annual Meeting

Oct 03, 2025
EVAX Evaxion Biotech A/S

Evaxion Out-Licenses Vaccine Candidate EVX-B3 to MSD in Major Partnership Deal

Sep 25, 2025
EVAX Evaxion Biotech A/S

Evaxion Reports Q2 2025 Financial Results and Business Updates

Aug 14, 2025
EVAX Evaxion Biotech A/S

Evaxion to Present Two-Year Clinical Efficacy Data for EVX-01 at ESMO Congress 2025

Jul 25, 2025
EVAX Evaxion Biotech A/S

Evaxion Finalizes Debt-to-Equity Conversion Agreement with European Investment Bank

Jul 11, 2025
EVAX Evaxion Biotech A/S

Evaxion Announces Executive Management Changes to Optimize AI-Immunology Platform and Portfolio Value

Jul 01, 2025
EVAX Evaxion Biotech A/S

Evaxion Expands R&D Pipeline with New Group A Streptococcus Vaccine Program EVX-B4

Jun 25, 2025
EVAX Evaxion Biotech A/S

Evaxion Receives Gates Foundation Grant to Design New Polio Vaccine

Jun 03, 2025
EVAX Evaxion Biotech A/S

Evaxion Reports Strong Q1 2025 Financial Results with Extended Cash Runway

May 27, 2025
EVAX Evaxion Biotech A/S

Evaxion Doses First Patient in EVX-01 Phase 2 Trial Extension to Explore Monotherapy Potential

May 22, 2025
EVAX Evaxion Biotech A/S

Evaxion Presents Striking EVX-01 Data at AACR Annual Meeting, Demonstrating 80% Immune Response Rate

Apr 28, 2025
EVAX Evaxion Biotech A/S

Evaxion Reports Full Year 2024 Financial Results and Business Update

Apr 01, 2025
EVAX Evaxion Biotech A/S

Evaxion Extends Phase 2 Trial for Personalized Cancer Vaccine EVX-01 to Three Years

Feb 25, 2025
EVAX Evaxion Biotech A/S

Nasdaq Confirms Evaxion's Compliance, Withdraws Delisting Determination

Feb 14, 2025
EVAX Evaxion Biotech A/S

Evaxion Closes $10.8 Million Public Offering with MSD Global Health Innovation Fund Participation

Jan 31, 2025
EVAX Evaxion Biotech A/S

Evaxion Granted Nasdaq Compliance Extension, Restores Equity Above Minimum Requirement

Jan 28, 2025
EVAX Evaxion Biotech A/S

Evaxion Completes Dosing in Phase 2 Trial for Personalized Cancer Vaccine EVX-01

Jan 15, 2025
EVAX Evaxion Biotech A/S

Evaxion Announces Plan to Implement ADS Ratio Change

Dec 30, 2024
EVAX Evaxion Biotech A/S

Evaxion Pursues Debt-to-Equity Conversion with European Investment Bank

Dec 17, 2024
EVAX Evaxion Biotech A/S

Evaxion Establishes New AI-Derived Precision Cancer Vaccine Concept with Preclinical Proof-of-Concept

Dec 12, 2024
EVAX Evaxion Biotech A/S

Evaxion Receives and Appeals Nasdaq Delisting Determination

Nov 13, 2024
EVAX Evaxion Biotech A/S

Evaxion Announces Positive Preclinical Data for CMV Vaccine Program EVX-V1

Nov 12, 2024
EVAX Evaxion Biotech A/S

Evaxion Reports Q3 2024 Financial Results and Business Progress

Oct 31, 2024
EVAX Evaxion Biotech A/S

Evaxion's AI-Immunology Platform Validated in Multiple Clinical Trials

Oct 09, 2024

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks